Joseph Duxbury - 10 Oct 2024 Form 3 Insider Report for Vireo Growth Inc. (VREOF)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
15 Oct 2024, 10:41:13 UTC
Next SEC filing
23 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Duxbury
Filing notes and source

Key filing fact

Joseph Duxbury filed Form 3 for Vireo Growth Inc. (VREOF) on 15 Oct 2024.

Key facts

  • This page summarizes Joseph Duxbury's Form 3 filing for Vireo Growth Inc. (VREOF).
  • 0 reported transactions and 5 derivative rows are listed below.
  • Accepted by SEC: 15 Oct 2024, 10:41.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VREOF holding

Subordiate Voting Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
3,000
Date
10 Oct 2024
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VREOF holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
10 Oct 2024
Ownership
Direct
Underlying class
Subordinate Voting Shares
Underlying amount
49,310
Exercise price
$0.1600
Footnotes
F1
VREOF holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
10 Oct 2024
Ownership
Direct
Underlying class
Subordinate Voting Shares
Underlying amount
30,000
Exercise price
$0.1600
Footnotes
F2
VREOF holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
10 Oct 2024
Ownership
Direct
Underlying class
Subordinate Voting Shares
Underlying amount
23,991
Exercise price
$0.1600
Footnotes
F3
VREOF holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
10 Oct 2024
Ownership
Direct
Underlying class
Subordinate Voting Shares
Underlying amount
50,000
Exercise price
$0.1700
Footnotes
F4
VREOF holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
10 Oct 2024
Ownership
Direct
Underlying class
Subordinate Voting Shares
Underlying amount
30,000
Exercise price
$0.2500
Footnotes
F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

The stock options were granted on January 3, 2023. 30,818 of the options vested immediately and 6.25% of the original grant vests each quarter thereafter until fully vested. The options expire on September 10, 2030.

Footnote F2

The stock options were granted on January 3, 2023. 16,875 of the options vested immediately and 6.25% of the original grant vests each quarter thereafter until fully vested. The options expire on November 29, 2030.

Footnote F3

The stock options were granted on January 3, 2023. 5,998 of the options vested immediately and 6.25% of the original grant vests each quarter thereafter until fully vested. The options expire on March 14, 2032.

Footnote F4

The stock options were granted on January 4, 2023. 12,500 of the options vested on December 31, 2023 and 6.25% of the original grant vests each quarter thereafter until fully vested. The options expire on January 3, 2033.

Footnote F5

The stock options were granted on December 21, 2023. 7,500 of the options vest on December 31, 2024 and 6.25% of the original grant vests each quarter thereafter until fully vested. The options expire on December 20, 2033.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .